iQ 008
Alternative Names: iQ-008Latest Information Update: 15 Sep 2022
Price :
$50 *
At a glance
- Originator iQure Pharma
- Class Non-opioid analgesics; Small molecules
- Mechanism of Action Calcium channel modulators; Sodium channel modulators; TRPV1 receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Neuropathic pain